Medicare Enrolled

Dr. Muhammad Bajwa, MD

Student in an Organized Health Care Education/Training Program · Sugar Land, TX
17520 W GRAND PKWY S STE 400, Sugar Land, TX 77479
2813440865
Registered in NPPES since 2017
NPI: 1306375795 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Bajwa from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bajwa? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Bajwa

Dr. Muhammad Bajwa is a student in an organized health care education/training program specialist in Sugar Land, TX, with 9 years of NPI registration.

Between the years covered by Open Payments, Dr. Bajwa received a total of $17,942 from 27 pharmaceutical and/or device companies across 125 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Bajwa is Moderate — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 9 years of NPI registration $17,942 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$17,942
Total received (2020-2024)
Avg $3,588/year across 5 years
Top 2% in TX for student in an organized health care education/training program
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
27
Companies
125
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,093
2023
$14,487
2022
$831
2021
$404
2020
$128

Payments by company (2024)

Edwards Lifesciences Corporation
$1,215
Abbott Laboratories
$192
iRhythm Technologies, Inc.
$150
CARDIVA MEDICAL, INC.
$140
AngioDynamics, Inc.
$125
Boston Scientific Corporation
$123
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$49
Novartis Pharmaceuticals Corporation
$31
Janssen Pharmaceuticals, Inc
$21
AstraZeneca Pharmaceuticals LP
$18
Inari Medical, Inc.
$14
Amgen Inc.
$14
Top 3 companies account for 74.4% of 2024 payments
All-time payments by company (2020-2024) ›
Boston Scientific Corporation
$6,242
Medtronic, Inc.
$3,707
Abbott Laboratories
$3,412
Edwards Lifesciences Corporation
$1,602
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$376
Inari Medical, Inc.
$293
Teleflex LLC
$286
HeartFlow, Inc.
$256
AstraZeneca Pharmaceuticals LP
$189
Impulse Dynamics (USA) Inc.
$157
iRhythm Technologies, Inc.
$150
W. L. Gore & Associates, Inc.
$142
CARDIVA MEDICAL, INC.
$140
ABIOMED
$130
Baxter Healthcare
$127
AngioDynamics, Inc.
$125
Chiesi USA, Inc.
$102
BIOTRONIK INC.
$99
Amgen Inc.
$73
Janssen Pharmaceuticals, Inc
$68
PFIZER INC.
$52
E.R. Squibb & Sons, L.L.C.
$52
Penumbra, Inc.
$48
Astellas Pharma US Inc
$47
Novartis Pharmaceuticals Corporation
$31
Lantheus Medical Imaging, Inc.
$23
GE HEALTHCARE
$12
Top 3 companies account for 74.5% of all-time payments
Associated products mentioned in payments ›
ABRE · ALPHAVAC · ANDEXXA · AVEIR · CAMZYOS · CARDIOMEMS · CARDIVA VASCADE MVP VVCS 6-12F · COREVALVE EVOLUT R · CT THROMBECTOMY SYSTEM KIT · Comet · DEFINITY · EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · ELIQUIS · EnSite Precision Cardiac Mapping System · FARXIGA · FFRct · FLOWTRIEVER CATHETER · FREESTYLE LIBRE 3 · GORE CARDIOFORM Septal Occluder · Hillrom - Carnation Ambulatory Monitor · IN.PACT ADMIRAL · Impella · Indigo System · KENGREAL · LEQVIO · LEXISCAN · LifeVest · MANTA · OPTIMIZER · Orsiro Mission · RAIDER · ROTAPRO · Repatha · S · SAPIEN 3 Ultra RESILIA · SYNERGY · Samurai RC · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · XARELTO · ZIO AT Patch · ZIO XT Patch · Zio monitor · iLab Ultrasound Imaging System
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a student in an organized health care education/training program specialist in Sugar Land?
Compare student in an organized health care education/training programs in the Sugar Land area by procedure volume, costs, and industry payment transparency.
Browse student in an organized health care education/training programs nearby

Geographic Context

Student in an organized health care education/training programs in nearby ZIP areas
4,895
County median income
$113,409
Nearest hospital to ZIP centroid (approximate)
HOUSTON METHODIST SUGARLAND HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data — No data N/A
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of Moderate. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Bajwa is a student in an organized health care education/training program specialist.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Bajwa receive payments from pharmaceutical companies?
Yes. Dr. Bajwa received a total of $17,942 from 27 companies across 125 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Bajwa) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →